You are here
MIAMIMolecular imaging detects the pathology that leads to Alzheimers disease years before the development of symptoms, which could allow physicians to detect signs of the disease in healthy patients, according to studies presented June 11 at the annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).
MIAMI -The routine clinical diagnostic accuracy for dementia hovers in the 50 to 80 percent range, yet the capability to differentiate Alzheimers disease, dementia with Lewy bodies and frontotemporal lobe dementia will be critical as therapeutic treatment strategies are identified. PET imaging with novel radiopharmaceuticals could provide physicians the key they need to unlock the mysteries of various dementias, Kirk A. Frey, MD, PhD, told the audience during the June 10 plenary session at the annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).
ORLANDO, Fla.Brigham & Womens Hospital in Boston, home to the Center for Evidence-Based Imaging, is a clinical decision support (CDS) pioneer and may be the original CDS success story. For more than a decade, the hospital has been building and implementing CDS systems, and its architects have learned more than few lessons along the way.